Pharmacometrics-based dose selection of levofloxacin as a treatment for postexposure inhalational anthrax in children
about
Alternative pre-approved and novel therapies for the treatment of anthraxBioavailability and efficacy of levofloxacin against Francisella tularensis in the common marmoset (Callithrix jacchus).Response-guided telaprevir therapy in prior relapsers? The role of bridging data from treatment-naïve and experienced subjects.IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults.Boceprevir dosing for late responders and null responders: the role of bridging data between treatment-naïve and -experienced subjects.Pediatric tuberculous meningitis: Model-based approach to determining optimal doses of the anti-tuberculosis drugs rifampin and levofloxacin for childrenEffect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and ChildrenApplications of pharmacometrics in the clinical development and pharmacotherapy of anti-infectives.Pharmacokinetics and Dosing of Levofloxacin in Children Treated for Active or Latent Multidrug-resistant Tuberculosis, Federated States of Micronesia and Republic of the Marshall Islands.Impact of pharmacometric analyses on new drug approval and labelling decisions: a review of 198 submissions between 2000 and 2008.The current role of model-based drug development.Safety and tolerability profile of second-line anti-tuberculosis medications.Antituberculosis drugs in children.Fluoroquinolones in children: update of the literature.Exposure Matching for Extrapolation of Efficacy in Pediatric Drug Development.Pharmacometrics 2020.Pharmacodynamically Guided Levofloxacin Dosing for Pediatric Community-Acquired Pneumonia.In vitro evaluation of the effect of linezolid and levofloxacin on Bacillus anthracis toxin production, spore formation and cell growth.Levofloxacin Use in the Neonate: A Case Series.Pharmacokinetics and pharmacodynamics of levofloxacin injection in healthy Chinese volunteers and dosing regimen optimization.Evaluation and optimisation of current milrinone prescribing for the treatment and prevention of low cardiac output syndrome in paediatric patients after open heart surgery using a physiology-based pharmacokinetic drug-disease model.
P2860
Q28075453-B66872DD-D869-45D9-B586-498930D1BBC0Q34108623-0D8AF743-77CA-49AD-9520-9F113D31A6DBQ34226129-935D1340-7158-41BC-B7CE-F1721D39B7E7Q34262840-D2A5C4A3-2727-4A21-BC8D-944BB1A58D9EQ34275551-A55655EF-7E8F-4E29-AEE4-A1FAC3F8FD24Q35742101-590CA79A-2A9A-4436-8ACA-4D2B9C3425D8Q36322918-35C168D6-E926-44C7-BF71-D9BC17B3D945Q37259653-6B3CFA0C-E463-4EAB-BF2A-C8A630AC7FEBQ37426165-CA16EC8D-F66C-48A3-B32F-5F5DFADA002AQ37927016-8E68997E-D987-462A-AE4E-AA8C0C582C68Q38028538-A98E4877-EE77-4C8F-8900-FB6EDB14DBFBQ38353565-E4D46AB5-A292-46BC-A80C-307D2405C24AQ38533435-5B36E184-426B-4B68-913D-F99604853CEAQ38534340-DD9A97CB-4697-4A10-97E5-3A7712E9FC87Q38797102-5DC3F3A7-DA7C-40E0-8A5F-E785BDD9A9D5Q39828337-FA358BE9-47E3-4772-B50A-4808F3D54254Q39977662-B2A2D395-29C9-4896-85F1-AC5260BFB5E2Q40474328-58AE917F-AD2D-4B11-93AA-2F2E1D6E1440Q41455427-10E2753A-DD74-4299-B999-693D4427D23EQ42042948-9702B790-E23D-42EC-914E-3BE7008AB047Q42608257-7B8B1FB2-2FA8-4285-AA52-0007A4664C86
P2860
Pharmacometrics-based dose selection of levofloxacin as a treatment for postexposure inhalational anthrax in children
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Pharmacometrics-based dose sel ...... halational anthrax in children
@ast
Pharmacometrics-based dose sel ...... halational anthrax in children
@en
Pharmacometrics-based dose sel ...... alational anthrax in children.
@nl
type
label
Pharmacometrics-based dose sel ...... halational anthrax in children
@ast
Pharmacometrics-based dose sel ...... halational anthrax in children
@en
Pharmacometrics-based dose sel ...... alational anthrax in children.
@nl
prefLabel
Pharmacometrics-based dose sel ...... halational anthrax in children
@ast
Pharmacometrics-based dose sel ...... halational anthrax in children
@en
Pharmacometrics-based dose sel ...... alational anthrax in children.
@nl
P2093
P2860
P356
P1476
Pharmacometrics-based dose sel ...... halational anthrax in children
@en
P2093
Christoffer W Tornoe
Gary J Noel
Partha Nandy
Shuchean Chien
P2860
P304
P356
10.1128/AAC.00667-09
P407
P577
2009-10-26T00:00:00Z